These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 32765584)
21. Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses. Cao W; Wang C; Zhang Y; Yang J; Luo X; Zhao Y; Wu M; Cheng S; Wang Y Eur J Med Res; 2024 Mar; 29(1):166. PubMed ID: 38475882 [TBL] [Abstract][Full Text] [Related]
22. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins. Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227 [TBL] [Abstract][Full Text] [Related]
23. Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma. Lu X; Li G; Liu S; Wang H; Zhang Z; Chen B Int J Gen Med; 2021; 14():3707-3717. PubMed ID: 34321916 [TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer. Gu C; Xiong X; Liu W Dis Markers; 2023; 2023():5223657. PubMed ID: 36798787 [TBL] [Abstract][Full Text] [Related]
25. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer. Hu F; Zhao L; Wang Y; Ye H; Tang H; Zhou J Open Med (Wars); 2022; 17(1):1935-1943. PubMed ID: 36561844 [TBL] [Abstract][Full Text] [Related]
26. Prognostic and clinical significance of Solute Carrier Family 7 Member 1 in ovarian cancer. Gong W; Chen Y; Zhang Y Transl Cancer Res; 2021 Feb; 10(2):602-612. PubMed ID: 35116394 [TBL] [Abstract][Full Text] [Related]
27. Predicting Panel of Metabolism and Immune-Related Genes for the Prognosis of Human Ovarian Cancer. Zhang L; Sun W; Ren W; Zhang J; Xu G Front Cell Dev Biol; 2021; 9():690542. PubMed ID: 34322485 [TBL] [Abstract][Full Text] [Related]
28. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis. Zheng X; Du Y; Liu M; Wang C Funct Integr Genomics; 2023 Jun; 23(2):196. PubMed ID: 37270717 [TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978 [TBL] [Abstract][Full Text] [Related]
30. Association Between Succinate Receptor SUCNR1 Expression and Immune Infiltrates in Ovarian Cancer. Zhang J; Zhang Q; Yang Y; Wang Q Front Mol Biosci; 2020; 7():150. PubMed ID: 33062639 [TBL] [Abstract][Full Text] [Related]
31. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma. Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of the glutathione S-transferase Mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance. Zhang J; Li Y; Zou J; Lai CT; Zeng T; Peng J; Zou WD; Cao B; Liu D; Zhu LY; Li H; Li YK Front Oncol; 2022; 12():968547. PubMed ID: 35965498 [TBL] [Abstract][Full Text] [Related]
33. High expression of Lin B; Zhang T; Ye X; Yang H Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602 [TBL] [Abstract][Full Text] [Related]
34. Decreased Expression of Integrin Subunits α3, α6, and α8 in the Branching Airway Mesenchyme of Nitrofen-Induced Hypoplastic Lungs. Takahashi T; Friedmacher F; Zimmer J; Puri P Eur J Pediatr Surg; 2018 Feb; 28(1):109-114. PubMed ID: 28701000 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox Family Members in Colorectal Cancer. Li Q; Pan Y; Cao Z; Zhao S Front Oncol; 2020; 10():582667. PubMed ID: 33014884 [No Abstract] [Full Text] [Related]
36. Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer. Sun X; Wang S; Li Q Front Genet; 2019; 10():879. PubMed ID: 31572453 [TBL] [Abstract][Full Text] [Related]
37. Associations of sirtuins with clinicopathological variables and prognosis in human ovarian cancer. He Q; Chen K; Ye R; Dai N; Guo P; Wang L Oncol Lett; 2020 Apr; 19(4):3278-3288. PubMed ID: 32256823 [TBL] [Abstract][Full Text] [Related]
38. Jiao Y; Li Y; Liu S; Chen Q; Liu Y Onco Targets Ther; 2019; 12():4141-4152. PubMed ID: 31213833 [No Abstract] [Full Text] [Related]
39. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis. Li Y; Li L J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725 [TBL] [Abstract][Full Text] [Related]
40. Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis. Cao T; Pan W; Sun X; Shen H J Ovarian Res; 2019 Oct; 12(1):101. PubMed ID: 31656201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]